Diane Mellett
Board member
Board of Directors
Targovax
Norway
Biography
Diane Mellett is a consultant to a number of biotech and medical device companies. She has qualified in both US and UK law and advises biotechnology companies in commercial contract and intellectual property matters. Ms Mellett was formerly General Counsel for Cambridge Antibody Technology (CAT) (LSE: NASDAQ) and led the secondary NASDAQ listing of that company as well as serving on the Board of Directors. During her time at CAT, Ms Mellett led a successful defense of a contractual dispute with Abbott Pharmaceuticals (now Abbvie) covering the company’s major collaboration partnership covering Humira® , the most successful revenue generating antibody therapy in the pharmaceutical industry to date. She is a UK citizen, and resides in France.
Research Interest
consultant , biotechnology , medical device companies, antibody therapy
